Status:
COMPLETED
Effects of an Empowerment-based Psycho-behavioral Program on Persons With Mild Cognitive Impairment
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
50-100 years
Phase:
NA
Brief Summary
This study aims to evaluate the effects of a 13-week empowerment-based psycho-behavioral program to improve neuropsychiatric symptoms, cognitive functions, and health-related quality of life among per...
Detailed Description
Dementia has become a global pandemic. It affects 50 million people worldwide and this number is projected to have a three-fold increase to over 150 million by 2050. Dementia is characterized by a pro...
Eligibility Criteria
Inclusion
- Aged 50 years old or above
- Able to communicate in Cantonese
- Diagnosis with MCI as defined by the following criteria:
- I. Presence of significant cognitive complaints as reflected by self-report II. Abnormal objective cognitive performance defined as \< 1.5 standard deviations from age and education matched normal persons on Hong Kong Chinese version of Montreal Cognitive Assessment (HK-MoCA), which is a 12-item instrument measuring cognitive functions, more details are outlined under the session of outcome measures III. Independence in daily living as evaluated through clinical interviews
Exclusion
- With the confirmed diagnosis of any forms of dementia
- With the confirmed diagnosis of psychiatric morbidities, or history with stroke, brain injury and other neurological conditions that may affect cognitive, behavioral, and emotional functioning which may confound outcome measurement and limit their participation in the study
- With hearing or visual impairment that may hinder participation in research activities
- Current use of any cognitive intervention or electromagnetic stimulation that confound cognitive outcomes
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2022
Estimated Enrollment :
171 Patients enrolled
Trial Details
Trial ID
NCT04723667
Start Date
September 1 2020
End Date
June 10 2022
Last Update
May 19 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rose Lin
Hong Kong, Hong Kong
2
University of Hong Kong
Hong Kong, Hong Kong